{"filings":[{"id":581756,"accession_number":"0001477449-26-000030","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2026-05-21T20:04:53+00:00","items":["5.07"],"status":"ready","headline":"Teladoc Health holds 2026 annual meeting; all director nominees elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All eight director nominees elected; David B. Snow, Jr. received 67.4M for (12.9M against).","Advisory say-on-pay approved with 71.2M for, 9.0M against, 1.2M abstain.","Ratification of EY as auditor approved with 122.6M for, 1.2M against.","Broker non-votes of 43.2M on director elections and say-on-pay; none on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93078,"accession_number":"0001477449-26-000026","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2026-04-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Health Q1 2026 Revenue Falls 2% to $613.8M, Net Loss Narrows to $63.8M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["First Quarter 2026 revenue of $613.8 million, down 2% year-over-year","Net loss improved to $63.8 million ($0.36 per share) from $93.0 million ($0.53 per share) in prior year","Adjusted EBITDA was $58.2 million, essentially flat year-over-year","Integrated Care segment revenue up 2% to $395.4 million; BetterHelp down 9% to $218.4 million","Company reaffirmed full-year 2026 outlook with revenue range $2.481B-$2.576B and adjusted EBITDA $267M-$306M"],"consensus_eps_estimate":null,"consensus_eps_actual":-0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":613845000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104405,"accession_number":"0001477449-26-000016","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Teladoc Health appoints Susan Salka, ex-AMN Healthcare CEO, to its board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Susan Salka appointed to Teladoc board effective March 30, 2026; will serve on audit and compensation committees.","She is former president and CEO of AMN Healthcare, with 33-year tenure; oversaw growth to $5B revenue.","Board expanded to nine members; Salka succeeds retiring directors Eric Evans and Thomas McKinley; Michael Smith previously appointed.","Salka is independent director and qualifies as audit committee financial expert under NYSE/SEC rules.","She currently serves on board of Parexel International and previously served on McKesson, Beckman Coulter, Playtex boards."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104404,"accession_number":"0001477449-26-000010","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Q4 revenue flat at $642M, net loss narrows; FY2026 revenue guidance $2.47-2.587B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $642.3M (flat YoY); net loss $25.1M vs $48.4M loss; adjusted EBITDA $83.8M (+12% YoY).","Full year 2025 revenue $2.53B (-2% YoY); net loss $200.3M vs $1.001B loss (lower goodwill impairment).","Integrated Care segment revenue +5% in Q4; BetterHelp -7%. FY Integrated Care adjusted EBITDA +3% to $239.2M.","FY2026 revenue guidance $2.47-2.587B; adjusted EBITDA $266-308M; free cash flow $130-170M.","Cash and equivalents $781.1M at year-end; Q4 free cash flow $53.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":2529977000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104403,"accession_number":"0001477449-26-000004","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Teladoc appoints Michael Smith, former Voya Financial CFO, to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointment of Michael Smith to board effective Feb 18, 2026; board size temporarily expanded to 10.","Smith served as Vice Chair and CFO of Voya Financial; brings over 30 years in financial services.","He will serve on audit and nominating/corporate governance committees.","Appointment follows previously announced retirements of directors Eric Evans and Thomas McKinley.","Teladoc to report Q4 2025 results on Feb 25, 2026, after market close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104402,"accession_number":"0001477449-26-000002","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Thomas G. McKinley to retire from Teladoc Health board effective Feb 20, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thomas G. McKinley, a director since 2009, notified Teladoc of his retirement effective Feb 20, 2026.","Retirement is for personal reasons and not due to any disagreement with the Company.","The Company thanked him for his dedicated service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120700,"accession_number":"0001477449-25-000126","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Teladoc director J. Eric Evans to retire at 2026 Annual Meeting, not standing for reelection","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["J. Eric Evans notified Teladoc on Dec 11, 2025 of intention not to stand for reelection at the 2026 Annual Meeting.","He will retire from the Board effective as of the conclusion of the 2026 Annual Meeting.","Evans has been a director since 2023, leaving for personal reasons; no disagreement with the company.","No replacement has been named at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120699,"accession_number":"0001477449-25-000122","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Teladoc Health increases inducement plan share reserve by 1.78M shares to 7.28M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved amendment effective Dec 9, 2025 to increase share reserve by 1,780,000 shares to total 7,280,000 shares under 2023 Inducement Plan.","Plan is used for equity awards to new employees as inducements without stockholder approval per NYSE Rule 303A.08.","Amendment filed as Exhibit 10.1; no other changes to Plan terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120698,"accession_number":"0001477449-25-000117","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Q3 revenue down 2% to $626.4M; net loss widens to $49.5M; adj. EBITDA falls 16%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $626.4M (-2% YoY); net loss $49.5M ($0.28 per share) vs. $33.3M loss a year ago.","Adjusted EBITDA $69.9M (-16% YoY); Integrated Care segment rev +2% to $389.5M; BetterHelp rev -8% to $236.9M.","Full-year 2025 guidance: revenue $2.51B-$2.539B; adj. EBITDA $270M-$287M; net loss per share ($1.25)-($1.10).","Cash from ops $99.3M in Q3; free cash flow $67.9M vs. $79.0M a year ago.","Non-cash goodwill impairment of $12.6M in Q3; $17.0M stock-based comp; $85.8M amortization intangibles."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":1887708000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120697,"accession_number":"0001477449-25-000114","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Teladoc Health CFO Mala Murthy resigns; preliminary Q3 revenue $626.4M, adj EBITDA $69.9M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Mala Murthy to resign effective Nov 21, 2025; interim finance leaders reporting to CEO.","Preliminary Q3 2025 consolidated revenue $626.4M, adjusted EBITDA $69.9M (unaudited).","Full-year 2025 consolidated revenue and adjusted EBITDA outlook reaffirmed (from July 29).","CFO search initiated; Murthy will present on Q3 earnings call Oct 29.","No GAAP EPS or segment details provided; full results to be released Oct 29."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137291,"accession_number":"0001477449-25-000096","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-07-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Q2 revenue $631.9M (-2% YoY); adjusted EBITDA $69.3M (-23%); retires $550.6M convertible notes","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $32.7M ($0.19 per share), improved from $837.7M loss in Q2 2024 which included $790M goodwill impairment.","Integrated Care segment revenue $391.5M (+4% YoY); BetterHelp revenue $240.4M (-9% YoY).","Paid $550.6M cash to retire convertible notes; entered a five-year $300M secured revolving credit facility on July 17.","Full-year 2025 revenue guidance $2,501–$2,548M; adjusted EBITDA $263–$294M; Q3 revenue guidance $614–$636M.","Free cash flow $61.2M in Q2 vs. $60.9M in Q2 2024; Capex $30.2M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":1261269000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137290,"accession_number":"0001477449-25-000091","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Teladoc Health enters $300M senior secured revolving credit facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Five-year $300M senior secured revolver with JPMorgan Chase as administrative agent; no immediate borrowings planned.","Interest rates: SOFR + 2.75%-3.25% or base rate + 1.75%-2.25%, based on secured net leverage ratio.","Financial covenants: max secured net leverage 3.50:1 (4.00:1 after certain acquisitions) and min interest coverage 3.00:1.","Proceeds to preserve financial flexibility; capital allocation priorities unchanged (balance sheet, organic/inorganic growth, share repurchases).","Obligations secured by substantially all assets of Teladoc and material domestic/foreign subsidiaries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154599,"accession_number":"0001477449-25-000063","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Teladoc shareholders approve 6.85M share increase for incentive plan; say-on-pay passes with 26.6% against","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to 2023 Incentive Award Plan, increasing authorized shares by 6,850,000.","All nine director nominees elected; David B. Snow Jr. received 19.9M against (23.9% against) and Kenneth Paulus received 10.9M against (13.1% against).","Advisory vote on executive compensation passed: 61.2M for, 22.2M against (26.6% against).","Ratification of Ernst & Young as independent auditor for FY2025 approved with 119.9M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154598,"accession_number":"0001477449-25-000047","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-04-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Q1 revenue down 3% to $629M; net loss widens on $59M goodwill impairment; acquires UpLift","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $629.4M (-3% YoY); net loss $93M ($0.53/sh) includes $59.1M goodwill impairment.","Integrated Care rev $389.5M (+3%), adj EBITDA margin 12.9%; BetterHelp rev $239.9M (-11%), adj EBITDA margin 3.2%.","Completed acquisition of UpLift Health for $30M cash plus up to $15M earnout; adds 100M+ covered lives.","FY 2025 outlook: rev $2.468-$2.576B, adj EBITDA $263-$304M, free cash flow $170-$200M.","Q2 2025 guidance: rev $614-$633M, adj EBITDA $56-$70M; BetterHelp rev expected to decline 7.5%-11.25% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":629369000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173132,"accession_number":"0001477449-25-000002","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2025-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Health Q4 revenue $640.5M (-3% YoY); full-year net loss $1.0B on $790M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $640.5M (-3% YoY); full-year revenue $2,569.6M (-1% YoY).","Q4 net loss $48.4M ($0.28/share); full-year net loss $1,001.2M ($5.87/share) includes $790M non-cash goodwill impairment in BetterHelp.","Q4 adjusted EBITDA $74.8M (-35% YoY); full-year adjusted EBITDA $310.7M (-5% YoY).","Integrated Care segment revenue +2% in Q4; BetterHelp segment revenue -10% in Q4, segment weakness persists.","2025 guidance: revenue $2,468-2,576M, adj. EBITDA $278-319M, net loss per share ($1.10)-($0.50); includes Catapult Health acquisition expected close Feb 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.87,"consensus_revenue_estimate":null,"consensus_revenue_actual":2569574000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190157,"accession_number":"0001477449-24-000224","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Q3 revenue $640.5M (-3% YoY), net loss narrows to $0.19 EPS; BetterHelp revenue down 10%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $640.5M (-3% YoY); net loss $33.3M ($0.19 per share) vs $57.1M loss last year.","Adjusted EBITDA $83.3M (-6% YoY); Integrated Care margin 17.7%, BetterHelp margin 5.9%.","BetterHelp revenue down 10% to $256.8M; nine-month goodwill impairment of $790M recorded.","Free cash flow $79.0M in Q3 vs $68.0M YoY; operating cash flow $110.2M.","Guidance: Integrated Care Q4 revenue growth 0-2.5%, FY24 adj. EBITDA margin ~15%."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":1929083000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190156,"accession_number":"0001477449-24-000216","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Teladoc Health COO Michael Waters resigns effective Dec 31, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["COO Michael Waters resigns with good reason due to change in executive reporting structure.","Resignation effective at close of business on December 31, 2024.","Severance includes 9 months base salary, COBRA premiums, 2024 bonus, and accelerated vesting of equity scheduled to vest within 9 months.","Conditions: remain employed through separation, sign release, and comply with 9-month non-compete and non-solicit.","Company thanks Mr. Waters for his service."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206664,"accession_number":"0001477449-24-000200","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-09-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Teladoc Health appoints Joseph Catapano as SVP and Chief Accounting Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph Catapano joined Teladoc as SVP and Chief Accounting Officer effective Sept 9, 2024.","Previously VP and CAO of Pitney Bowes (Aug 2017–Sept 2024); served as Interim CFO there.","Compensation: $375k base salary, $100k sign-on bonus, annual bonus target 40% of base, guaranteed 2024 bonus $150k.","Received 25,000 RSUs; 1/3 vests on first anniversary, rest quarterly starting 15 months post-grant.","Eligible for Level 13 Severance Plan; subject to one-year non-compete and non-solicitation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206663,"accession_number":"0001477449-24-000172","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Q2 revenue down 2% to $642.4M; net loss $837.7M on $790M goodwill impairment; FY outlook withdrawn","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $642.4M (-2% YoY); net loss $837.7M ($4.92/sh) includes $790M goodwill impairment for BetterHelp.","Adjusted EBITDA $89.5M (+24% YoY); Integrated Care +5% to $377.4M, BetterHelp -9% to $265.0M.","Company withdraws FY2024 consolidated and BetterHelp outlook and three-year outlook; provides Integrated Care guidance only.","New CEO Chuck Divita joined; comments on strengthening execution and streamlining organization.","Cash from operations $88.7M; free cash flow $60.9M; capex $27.7M."],"consensus_eps_estimate":null,"consensus_eps_actual":-5.44,"consensus_revenue_estimate":null,"consensus_revenue_actual":1288575000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206662,"accession_number":"0001477449-24-000168","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-07-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Teladoc Health terminates President Laizer Kornwasser without cause, effective July 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Laizer Kornwasser, President of Enterprise Growth and Global Markets, terminated without cause; effective July 1, 2024.","He will serve as Advisor to CEO until August 2, 2024, then depart.","Severance per Executive Employment Agreement dated October 24, 2022.","No replacement named; change in executive reporting structure cited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223847,"accession_number":"0001477449-24-000157","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-06-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Teladoc Health names Chuck Divita as CEO effective June 10, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Charles Divita appointed CEO and board member; Mala Murthy returns to CFO role.","Divita previously EVP Commercial Markets at GuideWell/Florida Blue, overseeing $23B in revenue.","New-hire equity award valued at ~$15M: 939,849 PSUs and 469,924 RSUs; base salary $800,000.","Company amended 2023 Inducement Plan, increasing reserved shares by 4M to 4.5M for CEO grants.","Mala Murthy's severance agreement amended to provide two years of enhanced severance protections."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223846,"accession_number":"0001477449-24-000122","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Teladoc Health reports 2024 annual meeting voting; all director nominees elected","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All eight director nominees elected; votes for ranged from 74.9M to 88.2M.","Say-on-pay approved with 86.0M for (95.9% of votes cast); 3.7M against.","Stockholders voted for 1-year frequency on future advisory votes (84.6M for one year).","Ratification of Ernst & Young as auditor passed with 119.5M for, 2.2M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223845,"accession_number":"0001477449-24-000099","cik":1477449,"company_name":"Teladoc Health, Inc.","ticker":"TDOC","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Teladoc Health Q1 revenue +3% to $646.1M; adjusted EBITDA +20% to $63.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $646.1M (+3% YoY); net loss $81.9M ($0.49 EPS) vs $69.2M loss in Q1 2023.","Integrated Care revenue +8% to $377.1M; BetterHelp revenue -4% to $269.0M.","Adjusted EBITDA rose 20% to $63.1M; free cash flow -$26.6M (improved from -$32.5M).","Q2 2024 outlook: revenue $635-660M, adj. EBITDA $70-80M, net loss per share ($0.45)-($0.35).","Full-year 2024 outlook: revenue $2,635-2,735M, adj. EBITDA $350-390M, FCF $210-240M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":646131000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1280740417.5842185,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}